Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib

NCT04874207 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT04874207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04874207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib
Lead sponsor
Rennes University Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 22, 2021
Completion date
April 11, 2025
Enrollment
110 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic